BAL PHARMA
Back to All Ratios
|
BAL PHARMA Last 5 Year EV/CE History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EV/CE(x) | 1.21 | 1.28 | 1.17 | 0.99 | 0.77 |
What is the latest EV/CE ratio of BAL PHARMA ?
Year | EV/CE |
---|---|
Mar2025 | 1.21 |
Mar2024 | 1.28 |
Mar2023 | 1.17 |
Mar2022 | 0.99 |
Mar2021 | 0.77 |
How is EV/CE of BAL PHARMA Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2025 | 1.21 | -5.47 | |
Mar2024 | 1.28 | 9.40 | |
Mar2023 | 1.17 | 18.18 | |
Mar2022 | 0.99 | 28.57 | |
Mar2021 | 0.77 | - |
Other Financial Ratios of BAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹132.2 Cr | -2.8% | -8% | -35.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,567.0 Cr | 0.5% | 4.6% | -18.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,601.0 Cr | -3.2% | -6.7% | 4.4% | Stock Analytics | |
CIPLA | ₹122,284.0 Cr | 0.3% | -3.5% | -10.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,593.0 Cr | 0.9% | -0.6% | 3.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,014.0 Cr | -2.2% | -0.9% | -9.4% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -2.8% |
-8% |
-35.4% |
SENSEX | -0.9% |
0.8% |
-5.7% |
You may also like the below Video Courses